| Biogen |
| Date/Time | / |
| Chg. / Chg.(%) | - / |
| Bid | - |
| Ask | - |
| Open | - |
| Previous Close | - |
| High | - |
| Low | - |
| Volume [USD] | - |
| Volume [Units] | |
| Price fixings | |
| ISIN | US09062X1037 |
| Security | BIIB |
| Exchange | IEX |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| NASDAQ | 265.0000 |  |
1,016,153 |
| IEX | 265.06 | |
88,687 |
| Cboe US | 265.07 | |
35,617 |
| London Inter.. | 265.43 | |
984 |
| TradeGate | 223.550 | |
457 |
| Xetra | 223.35 | |
99 |
| Stuttgart | 224.150 | |
53 |
| Frankfurt | 222.7500 | |
40 |
| gettex | 223.550 | |
7 |
| Vienna Globa.. | 223.20 | |
0 |
| München | 224.85 |  |
0 |
| Hamburg | 224.80 | |
0 |
| Düsseldorf | 224.20 | |
0 |
| Berlin | 224.30 | |
0 |
| Hannover | 224.80 | |
0 |
| SIX Swiss Ex.. | 232.00 | |
|
| Lang & Schwa.. | 223.850 | |
|
| Mexico | 5,815.00 |  |
54 |
News
- dpa-AFX-Überblick: UNTERNEHMEN vom 21.10.2020 - 15.15 Uhr
10/21/2020 / 15:20 - dpa-AFX - Biogen wird vorsichtiger wegen Konkurrenz bei Multiple-Sklerose-Mittel
10/21/2020 / 15:03 - dpa-AFX - Aktien New York Ausblick: Stabil erwartet - Snap überzeugt, Netflix enttäuscht
10/21/2020 / 15:03 - dpa-AFX - Biogen's Q3 revenue down 6% YoY to $3.38B
10/21/2020 / 13:04 - TeleTrader - ProMIS Neurosciences Offers its Perspective on the Likelihood of Regulatory Approval of Aducanumab
10/21/2020 / 12:30 - GlobeNewswire
Real-time